BioVoice News December 2017-January 2018 Issue 7 Volume 2 | Page 55

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: maximum protein expression; developing economical, flexible and robust manufacturing processes; and improving formulations for better dosage, stability and injectability. Additionally, appropriately defined cell culture conditions are required to achieve maximum protein expression. What are you addressing these challenges as a company to further boost your potential? Innovation Center to help customers address these challenges. This includes engaging biopharma customers in a